pfizer predicts revenue of $54 billion in 2022 from covid vaccine and antiviral pillface_vomitingface_vomitingface_vomitingface_vomitingface_vomitingface_vomitingface_vomitingface_vomitingface_vomitingogreface_vomitingcowboy_hat_facecowboy_hat_facecowboy_hat_face_